Stage 4 Papillary Thyroid Cancer: A Guide to Diagnosis, Treatment and Management

This morning, I read an advice column in which the person writing asked about her friend who keeps canceling plans due to depression, and the column author asked the letter writer if she would react the same way if her friend had a chronic or long term illness; the column author specifically mentioned cancer and asked if the letter writer would have the same opinion of the friend canceling if it was due to cancer treatment instead of depression.

A majority of counties across the U.S. are seeing a steady rise in vaccine exemptions for religious or personal beliefs among children entering kindergarten, a trend that has accelerated since the pandemic, according to a new study.

Findings from a literature review recently published in The American Journal of Public Health suggest that greater utilization of community oncology care can substantially reduce cancer-related financial toxicity—the economic burden of care—while maintaining equivalent, and in some cases superior, quality compared with hospital-based settings.1

A diagnosis of stage 4 papillary thyroid cancer is a significant life event, but it is important to understand that thyroid cancer is distinct from many other advanced malignancies.